Related Experiment Video
Updated: Aug 25, 2025

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
Published on: May 22, 2018
Revolutionizing cardiovascular medicine: targeted therapies for the cardiac conduction system
Daniel J Garry1,2,3, Demetris Yannopoulos1,2,3,4, Tamas Alexy1,2,3
1Cardiovascular Division, Medicine Department.
Insights
New imaging and therapy techniques allow real-time visualization and targeted treatment of the cardiac conduction system (CCS). This breakthrough offers potential for treating various cardiovascular diseases and improving patient outcomes.
Area of Science:
- Cardiovascular Research
- Medical Imaging
- Regenerative Medicine
Background:
- Arrhythmogenic cardiovascular disorders contribute significantly to morbidity and mortality.
- Current treatments for cardiac conduction disease are limited, necessitating novel therapeutic approaches.
- Understanding the cardiac conduction system (CCS) is crucial for developing effective interventions.
Purpose of the Study:
- To develop and apply advanced imaging technologies for real-time visualization of the CCS.
- To demonstrate the feasibility of delivering targeted therapies to specific components of the CCS.
- To explore the potential of these techniques for broader cardiovascular disease treatment.
Main Methods:
- Utilized state-of-the-art imaging technologies for in vivo visualization of the CCS.
- Developed methods for targeted therapeutic delivery to the CCS and its distinct cell lineages.
- Applied these techniques in an adult heart model.
Main Results:
- Successfully imaged the CCS in real time, providing unprecedented detail.
- Demonstrated successful targeted delivery of therapies to specific CCS components.
- Showcased the potential for lineage-specific treatment within the adult heart.
Conclusions:
- Advanced imaging and targeted therapy offer a promising new strategy for treating CCS disorders.
- These findings represent a significant step forward in the management of cardiovascular diseases.
- The developed technologies hold potential for broad applications in treating a range of cardiac conditions.
Abstract:
Arrhythmogenic cardiovascular disorders are associated with considerable morbidity and mortality. Whether cardiac conduction disease is caused by genetic defects, procedural perturbations, valvular disease, ischemia, aging, or heart failure, new therapies are warranted. In this issue of the JCI, Goodyer et al. used state-of-the-art technologies to image the cardiac conduction system (CCS) in real time and to deliver targeted therapies to the CCS and its subcomponents. These findings advance the ability to image and treat specific lineages within the adult heart with the potential for broader applications in the treatment of cardiovascular diseases.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Targeted Cancer Therapies
There are several types of targeted therapies against...

